Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3‐ and DP‐receptors
Open Access
- 1 March 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 111 (3) , 733-738
- https://doi.org/10.1111/j.1476-5381.1994.tb14799.x
Abstract
1 Spirally cut strips of the human saphenous vein and pulmonary artery were used to determine the pharmacological properties of the presynaptic prostanoid receptors involved in the modulation of sympathetic [3H]-noradrenaline release. Strips preincubated with [3H]-noradenaline were superfused with physiological salt solution containing inhibitors of uptake1 and uptake2 and rauwolscine to eliminate involvement of presynaptic α2-adrenoceptors. Tritium overflow was evoked by transmural electrical stimulation (standard frequency: 2 Hz). 2 In the saphenous vein, prostaglandin E2 (PGE2) inhibited the electrically-evoked tritium overflow; at the highest concentration investigated, tritium overflow was inhibited by more than 75% and the pEC50 value was 7.00. These effects were mimicked by prostaglandin E1, the EP1/EP3 receptor agonist, sulprostone and the EP2/EP3 receptor agonist, misoprostol with the rank order (pEC50): sulprostone (8.60) > PGE1 (7.25) > misoprostol (6.96). This rank order of potency suggests that the inhibitory effect of the drugs is mediated by presynaptic EP3-receptors. In contrast, PGF2α did not inhibit evoked tritium overflow; the IP/EP1 receptor agonist iloprost and the stable thromboxane A2 analogue U 46619 (9,11-dideoxy-11α,9α-epoxy-methanoprostaglandin F2α) produced inhibition only at concentrations above 1 μm. 3 The EP1-receptor antagonist, AH 6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) had no effect on the evoked tritium overflow nor did it modify the inhibitory effect of PGE2, further excluding involvement of inhibitory presynaptic EP1-receptors. 4 PGD2 caused a facilitation of evoked tritium overflow in the saphenous vein; this facilitation is probably mediated by presynaptic DP-receptors, since it was abolished by the selective DP-receptor antagonist, BW A868C (3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin). 5 In the pulmonary artery, sulprostone (pEC50 value 8.35), misoprostol (7.70) and PGE2 (6.80) inhibited electrically-evoked tritium overflow. This rank order of potency is consistent with the involvement of inhibitory presynaptic EP3-receptors. 6 These results suggest that the sympathetic nerve fibres of both human saphenous vein and pulmonary artery are endowed with presynaptic inhibitory EP3 receptors. The EP3-receptors do not interact with the α2-autoreceptors. In addition, the human saphenous vein seems to be endowed with presynaptic facilitatory DP-receptors.Keywords
This publication has 16 references indexed in Scilit:
- Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3‐subtypeBritish Journal of Pharmacology, 1992
- Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtypeBritish Journal of Pharmacology, 1991
- Prejunctional prostaglandin receptors in the human iris-ciliary bodyCurrent Eye Research, 1991
- The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonistBritish Journal of Pharmacology, 1989
- The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclaseBritish Journal of Pharmacology, 1989
- Identification of presynaptic β2‐adrenoceptors on the sympathetic nerve fibres of the human pulmonary arteryBritish Journal of Pharmacology, 1985
- Modulation of noradrenaline release in human saphenous vein via presynaptic α2-adrenoceptorsEuropean Journal of Pharmacology, 1984
- Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteriesProstaglandins, 1984
- The interactions of prostaglandins with the sympathetic nervous system—a reviewJournal of the Autonomic Nervous System, 1983